en
/
sv
About Elicera
Elicera in brief
Board
Team
Advisors
Elicera's history
Immuno-oncology
What is immuno-oncology?
Oncolytic virus
CAR T-cell therapy
Technology
CAR T-cell therapy
Challenges
Mode-of-action
Scientific publications
Pipeline
Pipeline
ELC-100
ELC-201
ELC-301
ELC-401
Clinical trials
Patent portfolio
Investors
Press Releases
Corporate Governance
the Share
Financial Reports
Financial Calendar
Events
IPO
Analyst Coverage
News
News
Press Releases
Events
Contact
en
/
sv
Management
Jamal El-Mosleh
CEO and co-founder
Ingvar Karlsson
Chief Financial Officer
Magnus Essand
Chief Scientific Officer and co-founder
Di Yu
Head of Translational Research and Technical Operations and co-founder
Anna Koptina Gültekin
Head of Regulatory Affairs
By continuing to browse this website you agree to cookies being stored on your device in order to improve the experience and analyze how it is being used. Read more in our
Integrity policy
.
Deny
Accept
